|
日本語版サンフォード感染症治療ガイド-アップデート版
|
|
シプロフロキサシンの脱感作 (2025/11/18 更新) |
概説
方法-経口
| 投与 |
CPFX濃度(mg/mL) |
投与全用量(mL) |
CPFX投与量(mg) |
CPFX累積投与量(mg) |
| 1 |
0.01 |
5.0 |
0.05 |
0.05 |
| 2 |
0.1 |
1.0 |
0.1 |
0.15 |
| 3 |
0.1 |
2.0 |
0.2 |
0.35 |
| 4 |
0.1 |
4.0 |
0.4 |
0.75 |
| 5 |
0.1 |
8.0 |
0.8 |
1.55 |
| 6 |
1.0 |
1.6 |
1.6 |
3.15 |
| 7 |
1.0 |
3.2 |
3.2 |
6.35 |
| 8 |
1.0 |
6.4 |
6.4 |
12.75 |
| 9 |
1.0 |
12.8 |
12.8 |
25.55 |
| 10 |
10.0 |
2.5 |
25.0 |
50.55 |
| 11 |
10.0 |
5.0 |
50.0 |
100.55 |
| 12 |
10.0 |
10.0 |
100.0 |
200.55 |
| 13 |
- |
- |
250mg錠 |
450.55 |
方法-静注
| 投与 |
CFPX濃度(mg/mL) |
投与全用量(mL) |
CPFX投与量(mg) |
CPFX累積投与量(mg) |
| 1 |
0.1 |
0.1 |
0.01 |
0.01 |
| 2 |
0.1 |
0.2 |
0.02 |
0.03 |
| 3 |
0.1 |
0.4 |
0.04 |
0.07 |
| 4 |
0.1 |
0.8 |
0.08 |
0.15 |
| 5 |
1.0 |
0.16 |
0.16 |
0.31 |
| 6 |
1.0 |
0.32 |
0.32 |
0.63 |
| 7 |
1.0 |
0.64 |
0.64 |
1.27 |
| 8 |
2.0 |
0.6 |
1.2 |
2.47 |
| 9 |
2.0 |
1.2 |
2.4 |
4.87 |
| 10 |
2.0 |
2.4 |
4.8 |
9.67 |
| 11 |
2.0 |
5 |
10 |
19.67 |
| 12 |
2.0 |
10 |
20 |
39.67 |
| 13 |
2.0 |
20 |
40 |
79.67 |
| 14 |
2.0 |
40 |
80 |
159.67 |
| 15 |
2.0 |
120 |
240 |
399.67 |